254 related articles for article (PubMed ID: 25446347)
21. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing.
Eroli F; Loonen ICM; van den Maagdenberg AMJM; Tolner EA; Nistri A
Neuropharmacology; 2018 Mar; 131():39-50. PubMed ID: 29225040
[TBL] [Abstract][Full Text] [Related]
22. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
23. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
25. CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.
Landucci E; Scartabelli T; Gerace E; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2011 Mar; 60(4):674-82. PubMed ID: 21130785
[TBL] [Abstract][Full Text] [Related]
26. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.
Hayase T; Yamamoto Y; Yamamoto K
J Pharm Pharmacol; 2001 Nov; 53(11):1525-32. PubMed ID: 11732755
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
[TBL] [Abstract][Full Text] [Related]
29. New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists.
Faúndez-Parraguez M; Alarcón-Miranda C; Cho YH; Pessoa-Mahana H; Gallardo-Garrido C; Chung H; Faúndez M; Pessoa-Mahana D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681877
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
31. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
32. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
33. Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is Sensitive to Anti-excitatory and Antioxidant Agents.
Maya-López M; Mireles-García MV; Ramírez-Toledo M; Colín-González AL; Galván-Arzate S; Túnez I; Santamaría A
Neurotox Res; 2018 Apr; 33(3):634-640. PubMed ID: 29313218
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine.
Elinos-Calderón D; Robledo-Arratia Y; Pérez-De La Cruz V; Maldonado PD; Galván-Arzate S; Pedraza-Chaverrí J; Santamaría A
J Neural Transm (Vienna); 2010 Jan; 117(1):35-44. PubMed ID: 19866339
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
Mendiguren A; Pineda J
Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
[TBL] [Abstract][Full Text] [Related]
36. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus.
D'Amico M; Cannizzaro C; Preziosi P; Martire M
Neurochem Res; 2004 Aug; 29(8):1553-61. PubMed ID: 15260134
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ
Elmazoglu Z; Rangel-López E; Medina-Campos ON; Pedraza-Chaverri J; Túnez I; Aschner M; Santamaría A; Karasu Ç
Neurochem Int; 2020 Nov; 140():104817. PubMed ID: 32781098
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.
Fan P
J Neurophysiol; 1995 Feb; 73(2):907-10. PubMed ID: 7760148
[TBL] [Abstract][Full Text] [Related]
40. Selenium-induced antioxidant protection recruits modulation of thioredoxin reductase during excitotoxic/pro-oxidant events in the rat striatum.
Maldonado PD; Pérez-De La Cruz V; Torres-Ramos M; Silva-Islas C; Lecona-Vargas R; Lugo-Huitrón R; Blanco-Ayala T; Ugalde-Muñiz P; Vázquez-Cervantes GI; Fortoul TI; Ali SF; Santamaría A
Neurochem Int; 2012 Jul; 61(2):195-206. PubMed ID: 22579569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
